Rheonix and Life Technologies Introduce Molecular Testing Platform
By LabMedica International staff writers
Posted on 25 Aug 2014
Rheonix, Inc., (Ithaca, NY, USA) solutions, and Life Technologies Corp. (Carlsbad, CA, USA) introduced a molecular testing platform for their Applied Markets business. The development agreement of Rheonix with Life Technologies addresses needs in the clinical diagnostics and food safety markets. Posted on 25 Aug 2014
Technology developed by Rheonix for the molecular diagnostics market, including the Rheonix CARD, a disposable cartridge the size of a credit card that can run multiple samples simultaneously without user intervention, and will be supplied by Rheonix to Life Technologies for marketing, sales, and distribution. The partnership will significantly shorten the time necessary for Rheonix to enter the clinical market with its sample-to-result molecular diagnostic instrument.
The instrument and consumable cartridges are components of a molecular detection system specifically designed for the food testing market that will enable laboratories to detect disease-causing organisms, including serotype identification, in a fully automated and highly efficient manner. The new platform is targeted for initial introduction in 2014.
Related Links:
Rheonix, Inc.
Life Technologies Corp.
Gold Member
Quantitative POC Immunoassay Analyzer
EASY READER+
New
Automatic CLIA Analyzer
Shine i6000
New
Hematology Consumables
Bioblood Devices
